f.petrov
TL2 Moderator · Konya
Contributes reviews on supplier material. Based in Konya.
Joined 13 August 2025 · last posted 3h
87 posts, newest first. Showing up to 150.
-
Injection timing and sleep disruption Replied, post #4 · Wellbeing › Sleep · 28 Jul 2026 · 0 likes Sleep apnoea improvement: as weight is lost, sleep apnoea usually improves. The timeframe is weeks to months, not immediate. Improvement often is gradual rather than…
-
Revisiting: Why the absence of controlled human data on BPC-157 matters more than people… Replied, post #55 · Compounds › Repair & healing peptides · 26 Jul 2026 · 0 likes post #54 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Follow-up: How compounding permissions changed when supply normalised Replied, post #72 · Sourcing › Regulatory · 25 Jul 2026 · 22 likes Approval versus licensing: a compound can be approved for a specific indication in one country and not approved at all in another. Tracking jurisdictional approval is…
-
Request: a per-category review queue Replied, post #116 · Meta › Feature requests · 20 Jul 2026 · 1 like Tradeoffs: every feature has a cost in maintenance and complexity. Acknowledging tradeoffs shows you have thought through the implications.
-
Coming back to: Telehealth prescribing models in the US Replied, post #19 · Regional › North America · 18 Jul 2026 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #80 · Start Here › Welcome · 13 Jul 2026 · 13 likes post #79 is right about the mechanism and I think understates the practical bit. There is no stupid-questions rule and no penalty for asking badly. The response to a…
-
The anatomy of a question that gets answered within an hour — does this still hold? Replied, post #6 · Start Here › How to Ask · 8 Jul 2026 · 3 likes Disagreement-style questions: "I read this and it contradicts what I heard here, which is right?" is answerable. "Is this a bad idea?" without giving the context is not.
-
CJC-1295 with and without DAC: what the modification does Replied, post #104 · Compounds › Secretagogues & GH axis · 6 Jul 2026 · 1 like post #103 is right about the mechanism and I think understates the practical bit. GHRH analogues versus ghrelin mimetics are often conflated but they are different…
-
Composite endpoints and the component doing the work Replied, post #5 · Evidence › Trials · 2 Jul 2026 · 21 likes Intent-to-treat versus per-protocol: ITT includes everyone assigned regardless of whether they took the drug. Per-protocol includes only those who completed it as…
-
Insurance and replacement policies, compared Replied, post #27 · Sourcing › Logistics · 18 Jun 2026 · 1 like This follows post #24 rather than contradicting it. Declaring contents accurately: declaring accurately reduces intervention risk. A declaration of "peptide research…
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #34 · Analytics › HPLC & UHPLC · 14 Jun 2026 · 10 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Cold solution and stinging: the simplest fix Replied, post #30 · Practice › Administration · 30 May 2026 · 8 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #51 · Outcomes › Progress reports · 27 May 2026 · 0 likes This follows post #48 rather than contradicting it. Plateaus and resets: if weight loss stalls and then resumes, that is ordinary. It is not evidence that the…
-
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #61 · Compounds › Repair & healing peptides · 27 May 2026 · 6 likes Why plausible mechanism is not evidence of effect: a mechanism that is chemically or biologically plausible can fail in practice for dozens of reasons —…
-
How shortages have affected compounding permissions — does this still hold? Replied, post #6 · Access › Shortages · 26 May 2026 · 12 likes Allocation and rationing: during severe shortages, suppliers might ration allocation to prescribers. Understanding rationing policies from your prescriber matters for…
-
Alcohol: what is documented and what is folklore Replied, post #22 · Practice › Interactions · 22 May 2026 · 11 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
A supplier who responds to a discrepancy with silence — what changed since Replied, post #42 · Sourcing › Red flags · 7 May 2026 · 12 likes Pricing patterns: unusually low prices for what are otherwise consistent with market rates might indicate lower quality, stolen goods, or a scam. Unusually high prices…
-
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #55 · Practice › Administration · 30 Apr 2026 · 0 likes This follows post #52 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add…
-
Micro-titration: a disputed topic, argued properly — one year on Replied, post #30 · Practice › Dosing & titration · 29 Apr 2026 · 17 likes Coming back to post #28, because the follow-up matters more than the original answer. How the published trials escalated: they used specific step sizes and intervals.…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #84 · Practice › Reconstitution · 23 Apr 2026 · 0 likes post #83 is right about the mechanism and I think understates the practical bit. Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) = 2.5…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #67 · Practice › Reconstitution · 22 Apr 2026 · 16 likes I read post #65 twice before replying, because I had assumed the opposite. How much of the diluent volume the powder itself displaces: for a small peptide vial, the…
-
Revisiting: Absolute versus relative contraindications Replied, post #59 · Safety › Contraindications · 5 Apr 2026 · 25 likes Picking up post #56: that is the part I would want checked first. Severe renal impairment (eGFR
-
The headache that turns out to be dehydration — the long version Replied, post #16 · Nutrition & Training › Hydration & electrolytes · 1 Apr 2026 · 5 likes post #15 answers the question as asked. The question underneath it is different. Exercise and electrolyte losses: sweating during exercise increases sodium and…
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #50 · Outcomes › Body composition · 30 Mar 2026 · 0 likes Changes during titration: measuring body composition during active titration is less useful than measuring after dose is stable. Titration causes fluid shifts that…
-
A single out-of-range value on an otherwise normal panel Replied, post #28 · Clinical › Bloodwork · 28 Mar 2026 · 1 like Biological variation: the person-to-person variation in a biomarker for a healthy person is larger than most people realize. Comparing your result to the reference…
-
Coming back to: Solubility limits and what a cloudy solution is telling you Replied, post #10 · Pharmacology › Formulation chemistry · 23 Mar 2026 · 11 likes Preservatives: solutions for multi-dose vials contain preservatives (benzyl alcohol, phenol, or others) to inhibit microbial growth after the vial has been entered.…
-
Amylin receptor signalling and satiety — what changed since Replied, post #46 · Pharmacology › Receptor biology · 17 Mar 2026 · 8 likes Coming back to post #44, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #68 · Pharmacology › Pharmacokinetics · 12 Mar 2026 · 4 likes Half-life: semaglutide ≈ 165–184 hours (about a week). Tirzepatide ≈ 5 days. Liraglutide ≈ 13 hours. The half-life determines how much accumulation happens at steady…
-
Follow-up: Lyophilisation and why the cake looks the way it does Replied, post #7 · marked as the solution · Pharmacology › Formulation chemistry · 6 Mar 2026 · 25 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Second pass at: Identical chromatograms across two different lots Replied, post #37 · Sourcing › Red flags · 2 Mar 2026 · 30 likes I read post #35 twice before replying, because I had assumed the opposite. Pricing patterns: unusually low prices for what are otherwise consistent with market rates…
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #135 · Access › International · 28 Feb 2026 · 0 likes Compounding in different countries: some countries allow pharmacy compounding under defined conditions; others do not. The rules are jurisdiction-specific and change.
-
[2026 update] A rising related-substance total over six months: degradation or method… Replied, post #52 · Analytics › Impurities & related substances · 17 Feb 2026 · 3 likes I read post #50 twice before replying, because I had assumed the opposite. Deamidation at asparagine and glutamine: adds 1 approximately. Frequently appears as a…
-
Second pass at: The topic list is dense — is that deliberate? Replied, post #73 · Meta › Site feedback · 16 Feb 2026 · 11 likes Community norms: if you think a norm has drifted or is not being followed consistently, raising it here can prompt discussion and realignment.
-
Mass error in ppm: the arithmetic and the caveat Replied, post #70 · Analytics › Mass spectrometry · 14 Feb 2026 · 18 likes post #69 answers the question as asked. The question underneath it is different. Charge states observed: for semaglutide (4113.6 Da) the doubly charged ion appears at…
-
Tag proliferation and whether we should prune — what changed since Replied, post #9 · Meta › Site feedback · 12 Feb 2026 · 23 likes Moderation decisions: if you disagree with a moderation decision, raising it here gives it visibility. Staff will reconsider if you make a substantive case.
-
Second pass at: What pooling buys you and what it destroys Replied, post #17 · Evidence › Meta-analyses · 11 Feb 2026 · 11 likes Worth separating two things that post #13 runs together. Fixed-effects versus random-effects models: fixed-effects assumes all studies are estimating the same thing and…
-
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #98 · Compounds › Oral incretins · 10 Feb 2026 · 1 like Worth separating two things that post #94 runs together. SNAC is the sodium N-(8-[2-hydroxybenzoyl]amino) caprylate, an absorption enhancer that transiently raises…
-
Reference intervals: how they are constructed and why one in twenty flags Replied, post #41 · Clinical › Bloodwork · 25 Jan 2026 · 23 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #39 · Documentation › Wiki requests · 15 Jan 2026 · 3 likes Format suggestions: if you think a maintained page could be clearer in its presentation (different section structure, different examples, added graphics) suggest the…
-
Managing an unplanned gap in supply Replied, post #2 · Access › Shortages · 7 Jan 2026 · 20 likes Picking up the opening post: that is the part I would want checked first. International supply chains: a shortage in one country does not mean shortage in another. That…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — the long… Replied, post #22 · Pharmacology › Receptor biology · 22 Dec 2025 · 7 likes Coming back to post #20, because the follow-up matters more than the original answer. Long-term receptor changes: very little is known about what happens to receptor…
-
[2026 update] Currency conversion and the cost you did not see Replied, post #4 · Sourcing › Payments · 18 Dec 2025 · 20 likes Payment mechanics: most suppliers accept bank transfer, crypto, and some accept credit cards. Each has different risk and different fees. Understand before you commit…
-
Aggregates and why a purity assay may miss them entirely Replied, post #5 · Analytics › Impurities & related substances · 12 Dec 2025 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #108 · Documentation › Doc review · 8 Dec 2025 · 1 like post #107 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
-
[2026 update] What steady state means for the decision to escalate Replied, post #71 · Practice › Dosing & titration · 12 Nov 2025 · 0 likes post #70 answers the question as asked. The question underneath it is different. Titrating on tolerability rather than on the calendar: some people escalate when they…
-
Documentation that appears only after payment Replied, post #74 · Sourcing › Red flags · 11 Nov 2025 · 30 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Pooling trials with different estimands — what changed since Replied, post #47 · Evidence › Meta-analyses · 6 Nov 2025 · 1 like I read post #45 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #88 · Practice › Reconstitution · 29 Oct 2025 · 3 likes On post #84 — agreed on the reasoning, with one qualification. A 10 mg vial reconstituted three different ways: 1 mL diluent gives 10 mg/mL, 2 mL gives 5 mg/mL, 4 mL…
-
Publishing an inconvenient result: a case study — the long version Replied, post #12 · Sourcing › Independent verification · 17 Oct 2025 · 24 likes Worth separating two things that post #8 runs together. Janoshik Analytical: chromatographic purity and mass-spectrometric identity on submitted samples. Reports are…
-
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #20 · Compounds › Semaglutide · 30 Sep 2025 · 25 likes Albumin binding is not a unique structural feature and nothing in the class lacks it, but the reversibility matters. Semaglutide binds albumin covalently through a…
-
Reading an interaction checker output critically Replied, post #7 · Practice › Interactions · 18 Sep 2025 · 0 likes Supplements and herbs: many have no established interaction. Some do. If you are taking something unusual, checking a reference (like a pharmacist) is more useful than…
-
Revisiting: Review: an evidence digest and the citation check that delayed it Replied, post #10 · Documentation › Doc review · 31 Aug 2025 · 28 likes Revision disputes: if you disagree with an edit a maintainer made to a page, discuss it here. The goal is accuracy and clarity, not authorship.
-
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #70 · Evidence › Journal club · 20 Aug 2025 · 28 likes SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome trial in people without diabetes, which decoupled the cardiovascular…
-
Insomnia at a dose step: reported experiences Replied, post #3 · Wellbeing › Sleep · 3 Aug 2025 · 20 likes Gastrointestinal effects overnight: nausea or reflux or constipation at night can disrupt sleep. Dosing timing (morning versus evening) might help if nighttime GI…
-
Publishing an inconvenient result: a case study Replied, post #51 · Sourcing › Independent verification · 18 Jul 2025 · 2 likes PeptideMeter: purity analysis plus structured, dated supplier verification records. Produces both individual analytical results and verification records assessed over…
-
Follow-up: Requesting a page: what makes a good request Replied, post #46 · Documentation › Wiki requests · 9 Jun 2025 · 0 likes Authority and authorship: if you think a maintained page needs input from someone with specific expertise (a clinician, an analytical chemist) suggest who might…
-
Second pass at: Trial registration and comparing the protocol with the paper Replied, post #12 · Evidence › Trials · 4 Jun 2025 · 9 likes This follows post #9 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add…
-
Pregnancy as an absolute contraindication Replied, post #17 · Safety › Contraindications · 17 May 2025 · 0 likes Allergy to the specific compound: true allergy is rare but possible. Any prior allergic reaction to the same compound or to structurally similar peptides warrants…
-
DXA precision and the least significant change for lean mass — the long version Replied, post #13 · Outcomes › Body composition · 7 May 2025 · 0 likes Bioelectric impedance analysis: less precise than DXA and strongly affected by hydration state. Not reliable for detecting month-to-month changes. Useful for trend over…
-
Coverage for the indication versus for the drug Replied, post #31 · Access › Insurance & coverage · 16 Apr 2025 · 0 likes post #30 answers the question as asked. The question underneath it is different. Denial letters: the stated reason tells you exactly what to submit next. A denial is…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #107 · Sourcing › Vendor reports · 18 Mar 2025 · 0 likes Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is water, counter-ion, and excipient. Purity and content are…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #64 · Sourcing › Regulatory · 2 Mar 2025 · 1 like Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Consistent declarations and why they matter more than clever ones Replied, post #109 · Sourcing › Logistics · 1 Mar 2025 · 24 likes This follows post #106 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
Consistent declarations and why they matter more than clever ones Replied, post #72 · Sourcing › Logistics · 23 Feb 2025 · 23 likes Worth separating two things that post #68 runs together. Documentation after arrival: photograph the parcel and its contents on arrival. If something later turns out…
-
Protein density versus volume when you cannot eat much Replied, post #100 · Nutrition & Training › Protein & intake · 9 Feb 2025 · 31 likes post #99 answers the question as asked. The question underneath it is different. Micronutrition alongside protein: eating protein foods that are also good sources of…
-
A promotion I argued against, and why I lost Replied, post #81 · Documentation › Doc review · 1 Feb 2025 · 0 likes post #80 answers the question as asked. The question underneath it is different. Citation checking: if a maintained page cites a paper, the citation should match what…
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #3 · Documentation › Doc review · 26 Jan 2025 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Reading a supplementary appendix and finding the interesting part Replied, post #76 · Evidence › Trials · 25 Jan 2025 · 0 likes Worth separating two things that post #72 runs together. Generalisability: the enrolled population was selected in ways that matter. Entry criteria, run-in periods, and…
-
Revisiting: What a well-designed human trial of a secretagogue would look like Replied, post #28 · Compounds › Secretagogues & GH axis · 12 Jan 2025 · 18 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Follow-up: Individual participant data versus aggregate data Replied, post #64 · Evidence › Meta-analyses · 10 Jan 2025 · 32 likes post #63 is right about the mechanism and I think understates the practical bit. Pooled estimates and heterogeneity: when trials differ in population, duration, or…
-
Turnaround times and what they mean for a decision — one year on Replied, post #28 · Sourcing › Independent verification · 8 Jan 2025 · 0 likes Blind sampling: submitting without the laboratory or seller knowing the source removes the two easiest ways for a result to be shaped: selective submission and…
-
What we do not know about retatrutide, listed explicitly Replied, post #48 · Compounds › Retatrutide · 8 Jan 2025 · 0 likes Picking up post #45: that is the part I would want checked first. Hepatic effects: glucagon receptor agonism promotes hepatic fat oxidation, which is mechanistically…
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #143 · Compounds › Oral incretins · 29 Dec 2024 · 2 likes Why an oral formulation is a formulation achievement: the molecule is the same but the tablet is novel. Getting a peptide across the gastric epithelium at usable…
-
Body image changing more slowly than the body Replied, post #99 · Wellbeing › Mental health · 22 Dec 2024 · 0 likes Identity and self-image: for some people, weight and body size are central to identity. Large change to body size can affect identity. This is not pathological; it is…
-
[2026 update] New subcategory: rationale and scope Replied, post #60 · Meta › Announcements · 12 Dec 2024 · 3 likes Questions welcomed: if an announcement is unclear, asking for clarification is welcome. Staff will explain their reasoning.
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #63 · Compounds › Tirzepatide · 30 Nov 2024 · 0 likes SURPASS-2 compared tirzepatide with semaglutide 1.0 mg, the licensed diabetes dose at that time. It did not compare with semaglutide 2.4 mg, the highest approved dose.…
-
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #28 · Practice › Reconstitution · 28 Nov 2024 · 28 likes Why "add 2 mL" is not an instruction: the powder in the vial takes up space. "Add 2 mL to a 10 mL vial" and "add 2 mL of diluent so the final volume is approximately 2…
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #34 · Access › Insurance & coverage · 20 Nov 2024 · 0 likes Appeals process: unemotional prose, the criterion quoted verbatim, evidence mapped to it point by point, dates, and nothing else. Describing how the decision affected…
-
EMA product information as a primary source — does this still hold? Replied, post #103 · Regional › European Union · 17 Nov 2024 · 0 likes Reimbursement varies substantially by member state. Some (Germany, France, Netherlands) restrict weight-management coverage. Others are more permissive. That variation…
-
EMA product information as a primary source — does this still hold? Replied, post #99 · Regional › European Union · 17 Nov 2024 · 0 likes Netherlands: CBG-MEB implements framework. GPs are first point of contact. Insurance coverage for weight management is conditional on structured lifestyle programme…
-
When to suspect the method rather than the sample Replied, post #23 · Analytics › Method validation · 13 Oct 2024 · 18 likes System suitability: injections run at the start of a batch to establish that the instrument and column are performing. Acceptance criteria typically include replicate…
-
Follow-up: What this community means by "a source", in practical terms Replied, post #9 · Start Here › Welcome · 11 Oct 2024 · 13 likes The moderation log is public. Every staff action is logged with the rule cited and the reasoning stated. If you get moderated, the explanation is there and it is worth…
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #31 · Compounds › Other compounds · 4 Oct 2024 · 3 likes On post #27 — agreed on the reasoning, with one qualification. Compounds this community declines to help with, and why: there are specifics in the guidelines and they…
-
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #91 · Sourcing › Independent verification · 28 Sep 2024 · 0 likes I read post #89 twice before replying, because I had assumed the opposite. Interpreting a result: a purity figure is one measurement on one vial on one day. Agreement…
-
The topic list is dense — is that deliberate? Replied, post #22 · Meta › Site feedback · 5 Sep 2024 · 23 likes Coming back to post #20, because the follow-up matters more than the original answer. Guideline clarity: if the guidelines are unclear or seem to be applied…
-
What a stability-indicating method is and how you demonstrate one — one year on Started this topic · Analytics › Method validation · 7 Jul 2024 · 11 likes What a stability-indicating method is and how you demonstrate one — one year on I have a specific reason for asking rather than idle curiosity, and the context is…
-
Spreadsheets: an appreciation Replied, post #19 · Lounge › Off topic · 8 Jun 2024 · 30 likes Newer drugs and mechanisms: when a new drug launches or a new mechanism is discovered, the Lounge is a place to discuss the news and speculate before hard data exists.